Mp70-06 Association of Socioeconomic Disadvantage and Insurance Type With Oncological Outcomes in Upper Tract Urothelial Carcinoma

You have accessJournal of UrologyDiversity, Equity & Inclusion: Health Equity & Outcomes III (MP70)1 May 2024MP70-06 ASSOCIATION OF SOCIOECONOMIC DISADVANTAGE AND INSURANCE TYPE WITH ONCOLOGICAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Jessica Chun, Sina Sobhani, Andrew Udov, Jamal Nabhani, and Hooman Djaladat Farshad Sheybaee MoghaddamFarshad Sheybaee Moghaddam , Alireza GhoreifiAlireza Ghoreifi , Jessica ChunJessica Chun , Sina SobhaniSina Sobhani , Andrew UdovAndrew Udov , Jamal NabhaniJamal Nabhani , and Hooman DjaladatHooman Djaladat View All Author Informationhttps://doi.org/10.1097/01.JU.0001008796.84999.75.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The impact of socioeconomic deprivation (SED) and type of health insurance on long-term outcomes is well-documented in various cancers. However, their effect on upper tract urothelial carcinoma (UTUC) remains unexplored. This study aims to investigate the impact of SED and health insurance on survival measures. METHODS: This single-center retrospective study utilized data from an IRB-approved, prospectively maintained, database of patients with UTUC who underwent surgery with curative intent between 2004 and 2022. Those with insufficient social or clinical data were excluded. The Area Deprivation Index (ADI) served as a proxy for SED and was categorized into four quartiles. Insurance types were classified as Health Maintenance Organization (HMO), Preferred Provider Organization (PPO), and Medicare. A multivariable analysis (MVA) was conducted to identify the factors that influence survival outcomes. RESULTS: Out of 414 patients with UTUC over the study interval, 380 patients were included. Baseline demographics and clinical features are detailed in Table 1. The Kaplan-Meier curve depicted in Figure 1 illustrates poorer OS in the high SED quartile. On MVA, high SED (OR 3.1, p=0.01) was an independent predictor for OS. Independent predictors of recurrence-free survival (RFS) are outlined in Table 2. No correlation was found between the type of health insurance and survival outcomes. Nevertheless, insurance type was associated with the length of follow-up, with a median (IQR) of 7 (1-15) months for HMO vs. 14 (4-21) and 12 (4-27) months for PPO plans and Medicare, respectively (p=0.02). CONCLUSIONS: Patients with UTUC residing in areas of high SED experience reduced overall survival, establishing SED as an independent prognostic factor for OS. Type of insurance was linked to the duration of follow-up and did not significantly impact survival outcomes. However, in cancers continuity of care is critical in the early identification and treatment of recurrence. Further research is necessary to corroborate these findings. Download PPT Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1130 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Farshad Sheybaee Moghaddam More articles by this author Alireza Ghoreifi More articles by this author Jessica Chun More articles by this author Sina Sobhani More articles by this author Andrew Udov More articles by this author Jamal Nabhani More articles by this author Hooman Djaladat More articles by this author Expand All Advertisement PDF downloadLoading ...